Altamonte Springs, FL1 Active Studies

Parkinsons Disease Clinical Trials in Altamonte Springs, FL

Find 1 actively recruiting parkinsons disease clinical trials in Altamonte Springs, FL. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
132
Enrolling

Recruiting Parkinsons Disease Studies in Altamonte Springs

About Parkinsons Disease Clinical Trials in Altamonte Springs

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 1 parkinsons disease clinical trials recruiting participants in Altamonte Springs, FL. These studies are seeking a combined 132 participants. Research is being sponsored by Intra-Cellular Therapies, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Altamonte Springs — FAQ

Are there parkinsons disease clinical trials in Altamonte Springs?

Yes, there are 1 parkinsons disease clinical trials currently recruiting in Altamonte Springs, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Altamonte Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Altamonte Springs research site will contact you about next steps.

Are clinical trials in Altamonte Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Altamonte Springs studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 1 active trials in Altamonte Springs are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated March 2, 2026 from ClinicalTrials.gov